1 recruiting, 1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Vin II: new trials by email Literature Review of Vin II trials Research Report on Vin II
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) Artesunate ointment, Placebo ointment - Vulvar Diseases, HPV Infection | Phase 2 | Recruiting | Frantz Viral Therapeutics, LLC | 27 | 2023-12-06 | 2025-08-14 |
| A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Recombinant Vaccine (Hansenula Polymorpha), Placebo - Cervical Cancer, Genital Wart | Phase 3 | Terminated | Shanghai Bovax Biotechnology Co., Ltd. | 3131 | 2022-12-09 | 2023-07-21 |
Condylomata Acuminata (1) · Papillomavirus Infections (1) · Uterine Cervical Neoplasms (1) · Vulvar Diseases (1)
Communicable Diseases (2) · DNA Virus Infections (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Infections (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Sexually Transmitted Diseases (2) · Sexually Transmitted Diseases, Viral (2) · Tumor Virus Infections (2) · Urogenital Diseases (2) · Virus Diseases (2)
Vaccines, Synthetic (1) · artemisinin (1) · artenimol (1) · artesunic acid (1)
Frantz Viral Therapeutics, LLC (1) · Shanghai Bovax Biotechnology Co., Ltd. (1)
China (1) · United States (1)